Treatment of TGF-β, which induces cell invasion as well as epithelial-mesenchymal-transition in many cancers, promotes the phosphorylation and nuclear export of TR3 to inhibit pro-apoptosis in cancer cells, while TR3 antagonists block TGF-β-induced nuclear export of TR3 [13]. This evidence concerns the gene NR4A1 and cancer.